JP2009530423A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009530423A5 JP2009530423A5 JP2009501727A JP2009501727A JP2009530423A5 JP 2009530423 A5 JP2009530423 A5 JP 2009530423A5 JP 2009501727 A JP2009501727 A JP 2009501727A JP 2009501727 A JP2009501727 A JP 2009501727A JP 2009530423 A5 JP2009530423 A5 JP 2009530423A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antibody
- chain variable
- variable region
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000024827 Alzheimer disease Diseases 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 210000004556 brain Anatomy 0.000 claims 5
- 230000004770 neurodegeneration Effects 0.000 claims 5
- 208000037259 Amyloid Plaque Diseases 0.000 claims 4
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 4
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 4
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 4
- 238000009825 accumulation Methods 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000006999 cognitive decline Effects 0.000 claims 4
- 208000010877 cognitive disease Diseases 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 4
- 230000003941 amyloidogenesis Effects 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 230000002195 synergetic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78457506P | 2006-03-21 | 2006-03-21 | |
| US89530307P | 2007-03-16 | 2007-03-16 | |
| PCT/US2007/064571 WO2007109749A2 (en) | 2006-03-21 | 2007-03-21 | Methods for preventing and treating amyloidogenic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009530423A JP2009530423A (ja) | 2009-08-27 |
| JP2009530423A5 true JP2009530423A5 (enExample) | 2011-05-26 |
Family
ID=38523302
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009501727A Withdrawn JP2009530423A (ja) | 2006-03-21 | 2007-03-21 | アミロイド生成性疾患を予防および処置するための方法 |
| JP2009501725A Pending JP2009529920A (ja) | 2006-03-21 | 2007-03-21 | Ｒａｇｅの拮抗作用のための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009501725A Pending JP2009529920A (ja) | 2006-03-21 | 2007-03-21 | Ｒａｇｅの拮抗作用のための方法および組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20070286858A1 (enExample) |
| EP (2) | EP2001907A2 (enExample) |
| JP (2) | JP2009530423A (enExample) |
| KR (2) | KR20080113236A (enExample) |
| AU (2) | AU2007226863A1 (enExample) |
| BR (2) | BRPI0708998A2 (enExample) |
| CA (2) | CA2646643A1 (enExample) |
| CR (2) | CR10298A (enExample) |
| EC (1) | ECSP088750A (enExample) |
| MX (2) | MX2008011933A (enExample) |
| NO (2) | NO20083720L (enExample) |
| RU (2) | RU2008134135A (enExample) |
| WO (2) | WO2007109747A2 (enExample) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| WO2005122712A2 (en) * | 2003-06-11 | 2005-12-29 | Socratech L.L.C. | Soluble low-density lipoprotein receptor related protein binds directly to alzheimer’s amyloid-beta peptide |
| PT1954718E (pt) | 2005-11-30 | 2014-12-16 | Abbvie Inc | Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos |
| KR20180058863A (ko) | 2005-11-30 | 2018-06-01 | 애브비 인코포레이티드 | 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도 |
| JP2009531324A (ja) | 2006-03-20 | 2009-09-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 癌標的化のための操作された抗前立腺幹細胞抗原（ｐｓｃａ）抗体 |
| WO2007109747A2 (en) * | 2006-03-21 | 2007-09-27 | Wyeth | Methods and compositions for antagonism of rage |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
| US8841421B2 (en) | 2007-04-26 | 2014-09-23 | Active Biotech, Ab | S100A9 interaction screening method |
| EP1986009A1 (en) * | 2007-04-26 | 2008-10-29 | Active Biotech AB | Screening method |
| WO2009032949A2 (en) | 2007-09-04 | 2009-03-12 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| CA2716801A1 (en) * | 2008-03-12 | 2009-09-17 | Wyeth Llc | Methods for identifying cells suitable for large-scale production of recombinant proteins |
| JP5646457B2 (ja) | 2008-04-29 | 2014-12-24 | アッヴィ・インコーポレイテッド | 二重可変ドメイン免疫グロブリン及びその使用 |
| KR101649168B1 (ko) * | 2008-05-09 | 2016-08-18 | 애브비 인코포레이티드 | 최종 당화 산물의 수용체(ｒａｇｅ)에 대한 항체 및 이의 용도 |
| JP2009276245A (ja) * | 2008-05-15 | 2009-11-26 | Shiseido Co Ltd | 持続性皮膚炎症性疾患の改善剤をスクリーニングする方法及びその改善剤 |
| AR072000A1 (es) * | 2008-06-03 | 2010-07-28 | Abbott Lab | Proteinas de union multivalentes con capacidad de unir dos o mas antigenos y usos de la misma |
| JP2011523853A (ja) | 2008-06-03 | 2011-08-25 | アボット・ラボラトリーズ | 二重可変ドメイン免疫グロブリン及びその使用 |
| BRPI0915448A2 (pt) | 2008-07-08 | 2015-11-10 | Abbott Lab | imunoglobulinas de domínio variável duplo para prostaglandina e2 e usos das mesmas |
| CA2731617A1 (en) * | 2008-07-22 | 2010-01-28 | Maria Joao Saraiva | Amino acid sequences directed against multitarget scavenger receptors and polypeptides |
| WO2010019656A1 (en) * | 2008-08-12 | 2010-02-18 | Wyeth | Humanized anti-rage antibody |
| CA2736904A1 (en) | 2008-09-26 | 2010-04-01 | Wyeth Llc | Compatible display vector systems |
| CA2737752A1 (en) * | 2008-09-26 | 2010-04-01 | Wyeth Llc | Compatible display vector systems |
| JP5832903B2 (ja) * | 2009-01-19 | 2015-12-16 | ビオメリューＢｉｏｍｅｒｉｅｕｘ | 院内感染罹患の患者の易罹患性を判定し、敗血症症候群の進行の予後を確立する方法 |
| WO2010096486A1 (en) | 2009-02-17 | 2010-08-26 | Cornell Research Foundation, Inc. | Methods and kits for diagnosis of cancer and prediction of therapeutic value |
| AU2010240569A1 (en) * | 2009-04-20 | 2011-10-20 | Pfizer Inc. | Control of protein glycosylation and compositions and methods relating thereto |
| KR20120060877A (ko) * | 2009-09-01 | 2012-06-12 | 아보트 러보러터리즈 | 이원 가변 도메인 면역글로불린 및 이의 용도 |
| EP2308896A1 (en) * | 2009-10-09 | 2011-04-13 | Sanofi-aventis | Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| EP2319871A1 (en) * | 2009-11-05 | 2011-05-11 | Sanofi-aventis | Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| WO2011042548A1 (en) * | 2009-10-09 | 2011-04-14 | Sanofi-Aventis | Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| TW201119676A (en) | 2009-10-15 | 2011-06-16 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
| UY32979A (es) | 2009-10-28 | 2011-02-28 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| US8420083B2 (en) | 2009-10-31 | 2013-04-16 | Abbvie Inc. | Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof |
| EP2506876B1 (en) | 2009-12-02 | 2016-10-12 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| MX336196B (es) | 2010-04-15 | 2016-01-11 | Abbvie Inc | Proteinas de union a amiloide beta. |
| EP3252072A3 (en) | 2010-08-03 | 2018-03-14 | AbbVie Inc. | Dual variable domain immunoglobulins and uses thereof |
| EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| SG187938A1 (en) | 2010-08-26 | 2013-04-30 | Abbvie Inc | Dual variable domain immunoglobulins and uses thereof |
| EP3252076B1 (en) | 2011-01-14 | 2019-09-04 | The Regents Of The University Of California | Diagnostic use of antibodies against ror-1 protein |
| US20120190925A1 (en) * | 2011-01-25 | 2012-07-26 | Oncofluor, Inc. | Method for combined imaging and treating organs and tissues |
| CN103460045B (zh) | 2011-04-05 | 2016-01-20 | 奥林巴斯株式会社 | 胰脏检查方法及胰脏检查试剂盒 |
| US9244074B2 (en) | 2011-06-07 | 2016-01-26 | University Of Hawaii | Biomarker of asbestos exposure and mesothelioma |
| WO2012170742A2 (en) | 2011-06-07 | 2012-12-13 | University Of Hawaii | Treatment and prevention of cancer with hmgb1 antagonists |
| CN104159920A (zh) | 2011-12-30 | 2014-11-19 | 艾伯维公司 | 针对il-13和/或il-17的双重可变结构域免疫球蛋白 |
| KR101477130B1 (ko) | 2012-01-11 | 2015-01-06 | 연세대학교 산학협력단 | 용해성 rage를 유효성분으로 포함하는 심근염의 예방 또는 치료용 약제학적 조성물 |
| WO2013177035A2 (en) | 2012-05-24 | 2013-11-28 | Alexion Pharmaceuticals, Inc. | Humaneered anti-factor b antibody |
| MY171664A (en) | 2012-11-01 | 2019-10-22 | Abbvie Inc | Anti-dll4/vegf dual variable domain immunoglobulins and uses thereof |
| JP2016522793A (ja) | 2013-03-15 | 2016-08-04 | アッヴィ・インコーポレイテッド | ＩＬ−１βおよび／またはＩＬ−１７に対して指向された二重特異的結合タンパク質 |
| CN105814079B (zh) | 2013-08-30 | 2021-02-09 | 伊缪诺金公司 | 用于检测叶酸受体1的抗体和测定 |
| CA2929077C (en) * | 2013-10-31 | 2024-05-28 | Amgen Inc. | Use of monensin to regulate glycosylation of recombinant proteins |
| EP3077823B1 (en) | 2013-12-05 | 2019-09-04 | The Broad Institute, Inc. | Compositions and methods for identifying and treating cachexia or pre-cachexia |
| EP3797793A1 (en) | 2014-04-18 | 2021-03-31 | The Research Foundation of the State University of New York at Buffalo | Humanized anti-tf-antigen antibodies |
| US10023651B2 (en) | 2014-04-18 | 2018-07-17 | The Research Foundation For The State University Of New York | Humanized anti-TF-antigen antibodies |
| WO2016061532A1 (en) * | 2014-10-16 | 2016-04-21 | The Broad Institute Inc. | Compositions and methods for identifying and treating cachexia or pre-cachexia |
| JP6679096B2 (ja) * | 2014-10-21 | 2020-04-15 | 学校法人 久留米大学 | Ｒａｇｅアプタマーおよびその用途 |
| WO2016094881A2 (en) | 2014-12-11 | 2016-06-16 | Abbvie Inc. | Lrp-8 binding proteins |
| WO2016201319A1 (en) * | 2015-06-10 | 2016-12-15 | The Broad Institute Inc. | Antibodies, compounds and screens for identifying and treating cachexia or pre-cachexia |
| WO2016201368A1 (en) | 2015-06-10 | 2016-12-15 | The Broad Institute Inc. | Antibodies, compounds and screens for identifying and treating cachexia or pre-cachexia |
| US10983114B2 (en) * | 2015-06-10 | 2021-04-20 | Stemcell Technologies Inc. | Method for the in situ formation of bifunctional immunological complexes |
| TW201710286A (zh) | 2015-06-15 | 2017-03-16 | 艾伯維有限公司 | 抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白 |
| WO2017027325A1 (en) | 2015-08-07 | 2017-02-16 | Imaginab, Inc. | Antigen binding constructs to target molecules |
| KR102700777B1 (ko) | 2015-09-17 | 2024-08-29 | 이뮤노젠 아이엔씨 | 항-folr1 면역접합체를 포함하는 치료제 조합 |
| EP3389715A4 (en) | 2015-12-14 | 2019-06-12 | David K. Thomas | COMPOSITIONS AND METHODS FOR TREATING CARDIAL DYSFUNCTION |
| JP7010491B2 (ja) * | 2016-04-11 | 2022-01-26 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク | ヒト化抗ｒａｇｅ抗体 |
| US11266745B2 (en) | 2017-02-08 | 2022-03-08 | Imaginab, Inc. | Extension sequences for diabodies |
| JP2020508054A (ja) | 2017-02-17 | 2020-03-19 | デナリ セラピューティクス インコーポレイテッドＤｅｎａｌｉ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | 抗タウ抗体及びその使用方法 |
| JP2020531514A (ja) | 2017-08-22 | 2020-11-05 | モナシュ・ユニヴァーシティ | 終末糖化産物受容体（ｒａｇｅ）の活性化のスクリーニングアッセイ、モジュレーター及び調節 |
| WO2020019095A1 (es) * | 2018-07-26 | 2020-01-30 | Universidad Católica Del Maule | Proteína rage (receptor de productos finales de glicacíon avanzada) como biomarcador de sensibilidad tumoral y evaluacion de terapia radiologica y radiomimética |
| US11621087B2 (en) * | 2019-09-24 | 2023-04-04 | International Business Machines Corporation | Machine learning for amyloid and tau pathology prediction |
| WO2023092082A1 (en) * | 2021-11-18 | 2023-05-25 | Bentley Cornelia | Antibodies to receptor of advanced glycation end products (rage) and uses thereof |
| WO2024077122A1 (en) * | 2022-10-05 | 2024-04-11 | The Regents Of The University Of California | Multipurpose, multi-functionalized lipid coated beads and methods of production |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196265A (en) * | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US6054561A (en) * | 1984-02-08 | 2000-04-25 | Chiron Corporation | Antigen-binding sites of antibody molecules specific for cancer antigens |
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5260203A (en) * | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US6893625B1 (en) * | 1986-10-27 | 2005-05-17 | Royalty Pharma Finance Trust | Chimeric antibody with specificity to human B cell surface antigen |
| US5041138A (en) * | 1986-11-20 | 1991-08-20 | Massachusetts Institute Of Technology | Neomorphogenesis of cartilage in vivo from cell culture |
| AU600575B2 (en) * | 1987-03-18 | 1990-08-16 | Sb2, Inc. | Altered antibodies |
| US5132405A (en) * | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5091513A (en) * | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5892019A (en) * | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| KR0162259B1 (ko) * | 1989-12-05 | 1998-12-01 | 아미 펙터 | 감염성 병변 및 염증성 병변을 검출 및 치료하기 위한 키메라 항체 |
| US6300129B1 (en) * | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
| GB9115364D0 (en) * | 1991-07-16 | 1991-08-28 | Wellcome Found | Antibody |
| US5625048A (en) * | 1994-11-10 | 1997-04-29 | The Regents Of The University Of California | Modified green fluorescent proteins |
| US5777079A (en) * | 1994-11-10 | 1998-07-07 | The Regents Of The University Of California | Modified green fluorescent proteins |
| US5871902A (en) * | 1994-12-09 | 1999-02-16 | The Gene Pool, Inc. | Sequence-specific detection of nucleic acid hybrids using a DNA-binding molecule or assembly capable of discriminating perfect hybrids from non-perfect hybrids |
| US5739277A (en) * | 1995-04-14 | 1998-04-14 | Genentech Inc. | Altered polypeptides with increased half-life |
| AU1832797A (en) * | 1996-01-26 | 1997-08-20 | Trustees Of Columbia University In The City Of New York, The | A polypeptide from lung extract which binds amyloid-beta peptide |
| US5864018A (en) * | 1996-04-16 | 1999-01-26 | Schering Aktiengesellschaft | Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor |
| US6124128A (en) * | 1996-08-16 | 2000-09-26 | The Regents Of The University Of California | Long wavelength engineered fluorescent proteins |
| EP2327797B1 (en) * | 1997-04-01 | 2015-11-25 | Illumina Cambridge Limited | Method of nucleic acid sequencing |
| WO2001012598A2 (en) * | 1999-08-13 | 2001-02-22 | The Trustees Of Columbia University In The City Of New York | METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| WO2002012437A2 (en) * | 2000-08-03 | 2002-02-14 | Schooten Wim Van | Production of humanized antibodies in transgenic animals |
| US7754208B2 (en) * | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| US20030133939A1 (en) * | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
| JP4171228B2 (ja) * | 2001-03-19 | 2008-10-22 | 第一ファインケミカル株式会社 | 可溶型ｒａｇｅ測定法 |
| US20040058445A1 (en) * | 2001-04-26 | 2004-03-25 | Ledbetter Jeffrey Alan | Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB |
| US7321026B2 (en) * | 2001-06-27 | 2008-01-22 | Skytech Technology Limited | Framework-patched immunoglobulins |
| US20060140933A1 (en) * | 2002-08-16 | 2006-06-29 | Wyeth And Imperial College Innovations Limited | Compositions and methods for treating rage-associated disorders |
| DE10244202A1 (de) * | 2002-09-23 | 2004-03-25 | Alstom (Switzerland) Ltd. | Elektrische Maschine mit einem Stator mit gekühlten Wicklungsstäben |
| CA2518371A1 (en) * | 2003-03-14 | 2004-09-30 | Wyeth | Antibodies against human il-21 receptor and uses therefor |
| EP1660186B1 (en) * | 2003-08-18 | 2013-12-25 | MedImmune, LLC | Humanization of antibodies |
| EP1660014A4 (en) * | 2003-09-05 | 2009-07-22 | Univ Columbia | RAGE-RELATED METHODS AND COMPOSITIONS FOR TREATING GLOMERULAR DAMAGE |
| KR100570422B1 (ko) * | 2003-10-16 | 2006-04-11 | 한미약품 주식회사 | 대장균 분비서열을 이용하여 항체 단편을 분비·생산하는 발현벡터 및 이를 이용하여 항체 단편을 대량 생산하는 방법 |
| WO2007109747A2 (en) * | 2006-03-21 | 2007-09-27 | Wyeth | Methods and compositions for antagonism of rage |
-
2007
- 2007-03-21 WO PCT/US2007/064568 patent/WO2007109747A2/en not_active Ceased
- 2007-03-21 CA CA002646643A patent/CA2646643A1/en not_active Abandoned
- 2007-03-21 MX MX2008011933A patent/MX2008011933A/es unknown
- 2007-03-21 JP JP2009501727A patent/JP2009530423A/ja not_active Withdrawn
- 2007-03-21 BR BRPI0708998-8A patent/BRPI0708998A2/pt not_active IP Right Cessation
- 2007-03-21 AU AU2007226863A patent/AU2007226863A1/en not_active Abandoned
- 2007-03-21 WO PCT/US2007/064571 patent/WO2007109749A2/en not_active Ceased
- 2007-03-21 JP JP2009501725A patent/JP2009529920A/ja active Pending
- 2007-03-21 MX MX2008012023A patent/MX2008012023A/es not_active Application Discontinuation
- 2007-03-21 AU AU2007226861A patent/AU2007226861A1/en not_active Abandoned
- 2007-03-21 KR KR1020087025056A patent/KR20080113236A/ko not_active Withdrawn
- 2007-03-21 RU RU2008134135/13A patent/RU2008134135A/ru not_active Application Discontinuation
- 2007-03-21 BR BRPI0708970-8A patent/BRPI0708970A2/pt not_active IP Right Cessation
- 2007-03-21 US US11/689,480 patent/US20070286858A1/en not_active Abandoned
- 2007-03-21 US US11/689,501 patent/US20070253950A1/en not_active Abandoned
- 2007-03-21 RU RU2008137764/13A patent/RU2008137764A/ru not_active Application Discontinuation
- 2007-03-21 EP EP07759057A patent/EP2001907A2/en not_active Withdrawn
- 2007-03-21 KR KR1020087025473A patent/KR20080110833A/ko not_active Withdrawn
- 2007-03-21 CA CA002638755A patent/CA2638755A1/en not_active Abandoned
- 2007-03-21 EP EP07759060A patent/EP2004694A2/en not_active Withdrawn
-
2008
- 2008-08-29 NO NO20083720A patent/NO20083720L/no not_active Application Discontinuation
- 2008-09-19 CR CR10298A patent/CR10298A/es not_active Application Discontinuation
- 2008-09-19 CR CR10297A patent/CR10297A/es not_active Application Discontinuation
- 2008-09-19 EC EC2008008750A patent/ECSP088750A/es unknown
- 2008-09-23 NO NO20084039A patent/NO20084039L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009530423A5 (enExample) | ||
| RU2008137764A (ru) | Способы предотвращения и лечения амилоидных заболеваний | |
| JP2020536532A5 (enExample) | ||
| JP2010526028A5 (enExample) | ||
| WO2008011348A3 (en) | Humanized antibody against amyloid beta | |
| JP2018510617A5 (enExample) | ||
| JP2018506277A5 (enExample) | ||
| JP2020513791A5 (enExample) | ||
| WO2008156622A8 (en) | Humanized antibodies to amyloid beta | |
| JP2009532378A5 (enExample) | ||
| JP2015514110A5 (enExample) | ||
| MX2009013503A (es) | Anticuerpo monoclonal anti-amiloide-beta. | |
| RU2010150105A (ru) | Гуманизированные антитела против альфа-интерферона человека | |
| JP2009539348A5 (enExample) | ||
| RU2552169C3 (ru) | Высокоаффинные человеческие антитела к pcsk9 | |
| RU2011117237A (ru) | АНТИТЕЛА ПРОТИВ Notch2 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| RU2011137369A (ru) | Способы лечения воспаления в нейронной ткани с применением моноклонального антитела или его связывающего фрагмента | |
| WO2008060364A3 (en) | Humani zed antibody against amyloid beta | |
| CA2494008A1 (en) | Anti-myelin associated glycoprotein (mag) antibodies | |
| JP2017536102A5 (enExample) | ||
| WO2006055809A3 (en) | Antibodies against vascular endothelial growth factor receptor-1 | |
| PH12011502389A1 (en) | Monoclonal antibody | |
| JP2010507594A5 (enExample) | ||
| JP2015504421A5 (enExample) | ||
| JP2017529324A5 (enExample) |